Pfizer's COVID Vaccine Works Wonders!

  Pfizer's COVID Vaccine Works Wonders! Its effectiveness against variants shows that the drug is on the gold standard in preventing COVID! When the pandemic began, people eagerly spent 2020 waiting for a vaccine to be found. During this time, Pfizer  PFE (NYSE) $39,05 +0,24 (+%0,63), BioNTech  BNTX (NASDAQ) $223,10 +10,68 (+%5,03), and Moderna vaccines and their results were far more successful than most had hoped. Unfortunately, the problems are not over, although daily cases in the US have now fallen by more than 95 % and most of the country has been vaccinated.

The Pfizer-BioNTech partnership is the first vaccine to share successful phase 3 data!

In mid-2020, it was announced that the vaccine was 95 percent effective in protecting against COVID-19. This was followed by Moderna  MRNA (NASDAQ) $209,19 +9,99 (+%5,02) with impressive results. Johnson & Johnson's has been the only company authorized for a single dose vaccine to date. Researchers, who had more of a static target in previous clinical trials, learned over time that there were actually different versions of the virus available.

Bigger, Stronger and Faster!

When viruses hijack a cell's machinery to make copies of itself, the duplications sometimes result in minor errors. Errors or mutations, we do not have much information about. Sometimes it can manifest as much more severe symptoms or a variant that is easier to spread. Both investors and the general public are focused on how well vaccines can protect against the virus!

Pfizer's COVID Vaccine Works Wonders!

Delta Variant, after England, announced that it is more contagious and causes more severe symptoms than other variants by the US Centers for Disease Control and Prevention (CDC).

Fortunately, the Pfizer vaccine protects itself against mutation!

CEO Albert Bourla stated that the mRNA vaccine has successfully passed the tests against variants and is effective against all variants. Results also show that two doses of the mRNA vaccine in the UK still provide significant protection against the mutated virus. White House medical adviser Dr. Anthony Fauci made a statement, "Although the same study has not yet been done with the Moderna vaccine, we expect its performance to be the same."

Conclusion

Pfizer and Moderna drugs are easy to adapt to new variants because they use RNA. Bourla said it is conducting a study to get regulatory approval within 100 days for Pfizer to roll out an updated vaccine. All of this suggests that the Pfizer vaccine is playing a more impressive role than first thought, as the Pandemic continues.    

Source: The Motley Fool

 

You also be interested in:

 

German Union Calls Amazon Workers to Strike!